Dexmedetomidine Reduces Sevoflurane EC50 for Supraglottic Airway Device Insertion in Spontaneously Breathing Morbidly Obese Patients

Therapeutics and Clinical Risk Management
doi 10.2147/tcrm.s199440
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited


Related search